ArticleFrontiers in immunology2025
Comparative analysis of neutrophil dynamics and disease in SARS-CoV-2 Delta and Omicron variants utilizing an
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SARS-CoV-2 Delta variant-specific ORF3a mutations destabilize lysosomal homeostasis to trigger lysosomal damage-mediated cell death.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Introduction: The emergence of SARS-CoV-2 variants, particularly Delta (B.1.617.2) and Omicron (XBB.1.5) variants, has substantially influenced the clinical and immunological landscape of COVID-19. This study investigates the differential pathogenicity and immune responses in a feline model infected with these variants, focusing on neutrophil activation, neutrophil extracellular trap (NET) formation, and cytokine profiles. Methods: Eight pathogen-free cats were inoculated with B.1.617.2 (Delta) SARS-CoV-2 (n=3), XBB.1.5 (Omicron) SARS-CoV-2 (n=3), or vehicle (n=2), and clinical assessments, histopathological examinations, and cytokine analyses were performed post-infection. Results: Results demonstrate that Delta-infected cats exhibit more severe clinical manifestations characterized by significant elevation in respiratory effort, wheezing, and systemic inflammation compared to Omicron-infected cats, which show milder symptoms, primarily confined to the upper respiratory tract. Histopathological findings suggest pronounced lung damage in Delta-infected cats, whereas Omicron infection resulted in localized pathology. Cytokine profiling demonstrates heightened proinflammatory responses, particularly in Delta-infected cats, characterized by elevated levels of IL-6, IFN-γ and TNF-α while Omicron infection results in less pronounced inflammatory responses. Moreover, neutrophil-related parameters, including total neutrophil counts and banded neutrophils, were significantly elevated in Delta-infected cats, correlating with enhanced NET formation as evidenced by increased NETs-related markers MPO, NE, and citrullinated H3, and NET-specific markers MPO-DNA complexes and cell-free DNA. Discussion: This study underscores the importance of variant-specific immune responses and highlights the need for targeted therapeutic strategies that mitigate severe lung injury associated with Delta infection, while also considering the distinct immune dynamics observed with the Omicron variant. Furthermore, results support the importance of delineating immune responses concerning future variants. These findings provide valuable insights into the pathogenesis of SARS-CoV-2 in companion animals and inform public health strategies as new variants continue to emerge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.